PHARMACOKINETICS OF LOW-DOSE ORAL MODIFIED RELEASE, SOLUBLE AND INTRAVENOUS ASPIRIN IN MAN, AND EFFECTS ON PLATELET-FUNCTION

被引：53

作者：

BOCHNER, F

WILLIAMS, DB

MORRIS, PMA

SIEBERT, DM

LLOYD, JV

机构：

[1] FH FAULDING & CO LTD,DIV RES & DEV,ADELAIDE,SA,AUSTRALIA

[2] INST MED & VET SCI,ADELAIDE,SA 5000,AUSTRALIA

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 35卷 / 03期

关键词：

D O I：

10.1007/BF00558267

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：287 / 294

页数：8

共 34 条

[1] PLASMA ACETYLSALICYLATE AND SALICYLATE AND PLATELET CYCLOOXYGENASE ACTIVITY FOLLOWING PLAIN AND ENTERIC-COATED ASPIRIN [J].

ALI, M ;

MCDONALD, JWD ;

THIESSEN, JJ ;

COATES, PE .

STROKE, 1980, 11 (01) :9-13

[2] IS THERE AN OPTIMAL DOSE AND FORMULATION OF ASPIRIN TO PREVENT ARTERIAL THROMBOEMBOLISM IN MAN [J].

BOCHNER, F ;

LLOYD, J .

CLINICAL SCIENCE, 1986, 71 (06) :625-631

[3] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[4] A SENSITIVE LIQUID-CHROMATOGRAPHIC ASSAY FOR PLASMA ASPIRIN AND SALICYLATE CONCENTRATIONS AFTER LOW-DOSES OF ASPIRIN [J].

BRANDON, RA ;

EADIE, MJ ;

SMITH, MT .

THERAPEUTIC DRUG MONITORING, 1985, 7 (02) :216-221

[5] SENSITIVITY OF FATTY-ACID CYCLOOXYGENASE FROM HUMAN AORTA TO ACETYLATION BY ASPIRIN [J].

BURCH, JW ;

BAENZIGER, NL ;

STANFORD, N ;

MAJERUS, PW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (10) :5181-5184

[6]

CHAM BE, 1980, THER DRUG MONIT, V2, P365

[7]

DANIEL WW, 1983, BIOSTATISTICS F ANAL

[8]

EMMETT JAG, 1987, CLIN EXP PHARM PHY S, V10, P78

[9] CONTROLLED TRIAL OF ASPIRIN IN CEREBRAL ISCHEMIA [J].

FIELDS, WS ;

LEMAK, NA ;

FRANKOWSKI, RF ;

HARDY, RJ .

STROKE, 1977, 8 (03) :301-316

[10]

FITZPATRICK FA, 1982, METHOD ENZYMOL, P286

← 1 2 3 4 →